The OLS has just launched the Biomanufacturing Fund (BMF) to support life science companies investing in manufacturing projects in the UK. The BMF will provide up to £38 million in capital grants to incentivise investment in the manufacture of vaccines and biotherapeutics, to improve the UK’s health resilience for future pandemics.
The BMF follows on from the £60m Life Sciences Innovative Manufacturing Fund (LSIMF) and will be using the same process as LSIMF for delivering the grants.
There are two upcoming opportunities to apply, with monthly deadlines of 30th June and 31st July. If you think you could benefit from this fund please contact the BMF team at bmf@officeforlifesciences.gov.uk You can find out more details about the fund at this webpage
Read our other news
Chester is set to become a leading fashion hub as it prepares to host the Porsche Centre Chester Cheshire Fashion Week 2024 this summer
Chester city centre business, Planned Future, has scooped up the Innovation & Excellence Award for its groundbreaking financial wellbeing portal
Chartered accountancy practice Bennettbrooks has relocated to a prominent new development in Chester.